Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

Company believes the presentation of non-GAAP financial measures provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of our ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators the Company uses as a basis for evaluating operational performance, allocating resources and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation or as a substitute for GAAP financial measures. To the extent this release contains historical non-GAAP financial measures, the Company has also provided corresponding GAAP financial measures for comparative purposes. Reconciliation between certain GAAP and non-GAAP measures is provided below.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "goal", "should", "would", "project", "plan", "predict", "intend", "target" and similar exp
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), announced that the Company is scheduled to ... The Company is scheduled to present at the Conference at ... Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... The leading companies in the cardiac ... rhythm management device market dominate their competition, according ... Jude Medical, Boston Scientific and Asahi Kasei (with ... The healthcare market research publisher,s report, Cardiac ... a base year, providing forecasts for each year ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... May 5, 2011 American Regent is conducting a ... following product: Caffeine & Sodium Benzoate Injection, USP, ... # 0517-2502-10, Lot # 0084,  Exp Date  February, 2012 ... 2011 to the User or Consumer Level, is for Lot # ...
... 2011 CareFusion Corp. (NYSE: CFN ), ... for the three and nine months ended March 31, ... "Our business performed well in the quarter, ... margins through a favorable product mix and disciplined expense ...
Cached Medicine Technology:American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 2American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 2CareFusion Reports Third Quarter Rise in Revenue, Earnings 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 4CareFusion Reports Third Quarter Rise in Revenue, Earnings 5CareFusion Reports Third Quarter Rise in Revenue, Earnings 6CareFusion Reports Third Quarter Rise in Revenue, Earnings 7CareFusion Reports Third Quarter Rise in Revenue, Earnings 8CareFusion Reports Third Quarter Rise in Revenue, Earnings 9CareFusion Reports Third Quarter Rise in Revenue, Earnings 10CareFusion Reports Third Quarter Rise in Revenue, Earnings 11CareFusion Reports Third Quarter Rise in Revenue, Earnings 12CareFusion Reports Third Quarter Rise in Revenue, Earnings 13CareFusion Reports Third Quarter Rise in Revenue, Earnings 14
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the second ... of individual international health insurance. Titled: The Cost of Health Insurance ... health insurance in six top expat destinations, which are also popular ... Kong , Singapore , China , ... UK , Article 2 presents an in-depth look at ...
(Date:5/24/2015)... 24, 2015 Women's Excellence in ... loss. Although it is unclear about the etiology of ... factors such as metabolism, nutritional deficiencies, thyroid abnormalities and ... a comprehensive approach to evaluating the metabolic, nutritional and ... can help patients find a cause for their problem. ...
(Date:5/24/2015)... Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... will allow them to take pressure measurements in patients’ ... function. The doctor usually orders it if they have ... bladder (OAB). , Women’s Excellence in Bladder ... problems with unwanted urinary leakage or problems with overall ...
(Date:5/24/2015)... 24, 2015 EnviroLeather™ by LDI, ... Plus” – a classic, rugged leather grain with ... difficult stains, including ink, to be easily removed. ... suitable for corporate, healthcare, hospitality and education environments. ... EnviroLeather’s goal of developing products that are more ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2
... of access to medical care a big factor in ... half of the Americans who meet the criteria for ... survey indicates. , "There is a definite gap between ... an internist in the Yale University Robert Wood Johnson ...
... specializing in Medicare supplement insurance plans, says MARS Act could ... access to necessary services. , ... ... news, according to MedicareSupplementPlans.com: Legislation designed to remove Medicare’s annual ...
... Clients Prepare and RespondPHILADELPHIA, April 24 International SOS ... information regarding the swine flu outbreak to members of ... http://urgent.interna t ionalsos.com , ... to frequently asked questions that those in California, Texas ...
... Telemedicine Inc. announces the completion of its transformation from a telemedicine ... (TEMS™) , ... North Chelmsford, MA (PRWEB) April 24, ... transformation to a Telemedicine Encounter Management Systems company. AMD will ...
... allows for remote physician participation in real time ... -- Scottsdale, Ariz.-based GlobalMedia, an innovator ... in the practice of telemedicine, announced today that ... product line, the TransportAV, at the American Telemedicine ...
... United American Healthcare Corporation (Nasdaq: UAHC ... a managed care organization in Tennessee, today announced it ... quarter ended March 31, 2009 on Thursday, May 7, ... a conference call at 4:30 p.m. Eastern time the ...
Cached Medicine News:Health News:Many Who Should Use Statins Don't 2Health News:Many Who Should Use Statins Don't 3Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:International SOS Releases Web Site to Educate Public About Swine Flu Outbreak 2Health News:AMD Global Telemedicine Inc. to Unveil New Solutions at ATA 2009 Conference in Las Vegas 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 3Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 4Health News:United American Healthcare Corporation to Host Fiscal 2009 Third Quarter Results Conference Call May 7th 2
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
2.5V Incandescent source, 3X magnification, pocket-sized....
Pocket-sized instrument with 2.5X magnification....
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 2.5V halogen ... of examination area. Used ...
Medicine Products: